Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• ACCEL Lite: Putting it All Together: Cardiogenic Shock Management in 2025 
  In this episode, Drs. Glenn A. Hirsch and Shashank S. Sinha explore the latest strategies in cardiogenic shock management in 2025, emphasizing the how the new guidance integrates clinical decision-making tools and highlighting the role of shock teams and regional partnerships in optimizing care delivery.
• The Relationship Between Exercise and Longevity: Challenging the U-Shaped Hypothesis
  Based on epidemiologic studies, it has been posited that there is a U- or reverse J-shaped relationship between exercise and cardiovascular outcomes. The benefits of regular exercise on longevity are well described...
• New ACC Guidance Addresses Obesity Treatment Strategies Across the CV Spectrum
  As obesity continues to drive cardiovascular risk, the ACC has released two new guidance documents to support clinicians: Concise Clinical Guidance (CCG) on the medical management of obesity and a Scientific Statement focused on treating obesity in adults with heart failure.
• Management of Recurrent Coarctation in Children
  Coarctation of the aorta accounts for 5-8% of all congenital heart disease, with an incidence of approximately four cases per 10,000 live births. It can be seen in isolation or associated with other cardiac lesions.
• Oral, Subcutaneous Amycretin Similarly Safe, Tolerated as GLP-1 Monoagonists
  Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist has a safety and tolerability profile similar with other GLP-1 and amylin agonists in both oral and subcutaneous formulations, according to two studies published in The Lancet.